ReviewActions of estrogens and endocrine disrupting chemicals on human prostate stem/progenitor cells and prostate cancer risk
Highlights
► Early-life estrogen/EDC exposures heighten prostate cancer susceptibility with aging. ► Prostate stem/progenitor cells express ERs and are targets for estrogenic actions. ► Estrogen/EDC modulate prostate stem cell self-renewal and differentiation capabilities. ► Estrogenic actions on stem/progenitor cells may increase prostate carcinogenic risk.
Introduction
Prostate cancer is the most common non-cutaneous cancer and the second leading cause of cancer deaths in North American men (Jemal et al., 2010). It is known that steroids play a role in the initiation and progression of prostate cancer, which is the basis for hormonal treatment strategies that include androgen ablation and androgen receptor (AR) blockade (Eisenberger et al., 1998, Huggins and Hodges, 1941). Increasing evidence indicates that in addition to androgens, estrogens play key roles in prostate carcinogenesis and progression, although the mechanisms are not fully understood (Ellem and Risbridger, 2007, Hu et al., 2011, Leung et al., 2010, Nelles et al., 2011, Prins et al., 2007, Prins and Korach, 2008). In men, chronically elevated estrogens have been associated with increased risk of prostate cancer (Modugno et al., 2001) while in rodents, estrogens in combination with androgens induce prostate cancer (Bosland, 1996). It is recognized that age, race, genetics (family history), diet, and environmental factors can impact prostate cancer risk (Reuben et al., 2010). Endocrine disrupting chemicals (EDCs) are a class of environmental toxicants that interfere with endocrine signaling pathways. In addition to direct effects in adults, strong evidence indicates that developing tissues are particularly sensitive to EDCs and that early-life EDC exposures promote specific disorders in adults (Foran et al., 2002, Heindel, 2005), a phenomenon referred to as the developmental basis of adult disease.
Recent advances in stem cell research indicate that stem cells and early stage progenitor cells may be direct carcinogenic targets and the cells of origin in cancer initiation and progression. Together with our previous findings in animal models which show that early-life exposures to natural and environmental estrogens increase susceptibility to prostate carcinogenesis through structural and epigenomic reorganization (Ho et al., 2006, Prins, 1992, Prins and Birch, 1997, Prins et al., 1993, Prins, 1997, Prins et al., 2008, Prins et al., 2011, Prins and Ho, 2010), we hypothesize that developmental reprogramming of the prostate gland by EDCs may involve epigenomic alterations in prostate stem/progenitor cells during early gland formation, thus predisposing to prostate cancer upon aging. At present, there is a critical need to determine whether early life estrogenic reprogramming of prostate cells similarly occurs in humans. To meet this current need, we have recently developed novel in vitro and in vivo models using stem and early stage progenitor cells isolated from normal human prostates and used these to initiate hormonal carcinogenesis (Hu et al., 2011). Importantly, these in vitro prostasphere and in vivo chimeric prostate models with carcinogenic induction can serve as suitable models for examining stem cell perturbations and carcinogenic actions of EDCs on human prostate cells. In the current review, we will briefly assess available evidence for EDCs and increased prostate cancer risks, discuss recent advances in prostate stem cell research, and present evidence for reprogramming of human prostate stem/progenitor cells by estrogens and EDCs using our novel human prostasphere and chimeric prostate models.
Section snippets
Endocrine disruptors and prostate cancer risk
In the human population, direct connections between EDCs and prostate cancer are primarily limited to epidemiology studies and in vitro analysis using cancer cell lines (Prins, 2008). These findings are supported by in vivo studies in animal models that suggest associations between EDCs and prostate cancer, carcinogenesis and/or susceptibility. Herein we will highlight the evidence on EDCs with estrogenic actions. For the sake of simplicity, we here refer to environmental estrogens as molecules
Prostate stem/progenitor cells
The prostate gland contains a simple columnar epithelium with three differentiated cell types – basal, luminal, and neuroendocrine cells – that are embedded in a fibro-muscular stroma (Isaacs et al., 1981, Wang et al., 2001). The major epithelial cell population is luminal secretory cells which express cytokeratins (CK) 8/18 and AR and are androgen-dependent for growth, survival and production of secretory proteins such as prostate specific antigen (PSA). Basal epithelial cells are interspersed
Estrogens and EDCs action on human prostate stem/progenitor cells
As the property of self-renewal allows for a long life span of stem cells, undifferentiated stem/progenitor cells are highly susceptible to environmental injuries over time and have the capacity to transmit their “injury memory” to the differentiated progeny (Cheng et al., 2008). Since the prostate gland is most susceptible to environmental insults during early development, it is reasonable to predict that prostate stem and early stage progenitor cells may be the primary targets of estrogenic
Acknowledgements
This work was supported by NIH Grants RC2 ES018758, R01 ES015584 and R03 CA136023.
References (114)
Chemical and hormonal induction of prostate cancer in animal models
Urol. Oncol.
(1996)- et al.
Arsenic and cancers
Lancet
(1988) - et al.
Stem cell features of benign and malignant prostate epithelial cells
J. Urol.
(1998) - et al.
ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy
Life Sci.
(2010) - et al.
Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation
Cell Stem Cell
(2008) Identification, characterization, and biological relevance of prostate cancer stem cells from clinical specimens
Urol. Oncol.
(2009)- et al.
An evaluation of evidence for the carcinogenic activity of bisphenol A: report of NIEHS expert panel on BPA
Reprod. Toxicol.
(2007) - et al.
A dioxin sensitive gene, mammalian WAPL, is implicated in spermatogenesis
FEBS Lett.
(2005) - et al.
Measurement of bisphenol A levels in human blood serum and ascitic fluid by HPLC using a fluorescent labeling reagent
J. Pharm. Biol. Anal.
(2003) - et al.
Maternal and fetal exposure to bisphenol A in Korea
Reprod. Toxicol.
(2008)
Stem cells in adult tissues
Semin. Cell Dev. Biol.
The role of estrogens and estrogen receptors in normal prostate growth and disease
Steroids
Developmental estrogen exposures predispose to prostate carcinogenesis with aging
Reprod. Toxicol.
Serum bisphenol A pharmacokinetics and prostatic responses following oral and subcutaneous exposures in neonatal Sprague–Dawley rats
Reprod. Toxicol.
Use of agricultural pesticides and prostate cancer risk in the Agricultural Health Study cohort
Am. J. Epidemiol.
Plasma organochlorine levels and prostate cancer risk
J. Expo. Sci. Environ. Epidemiol.
Estrogen signaling and disruption of androgen metabolism in acquired androgen-independence during cadmium carcinogenesis in human prostate epithelial cells
Prostate
Inorganic arsenic and human prostate cancer
Environ. Health Prospect.
Mechanisms of acquired androgen independence during arsenic-induced malignant transformation of human prostate epithelial cells
Environ. Health Perspect.
Wnt signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics
Cell Res.
Characterization of benign and malignant prostate epithelial Hoechst 33342 side populations
Prostate
Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue
PNAS
Exposure to bisphenol A and other phenols in neonatal intensive care unit premature infants
Environ. Health Perspect.
Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003–2004
Environ. Health Prospect.
Electromagnetic fields, polychlorinated biphenyls, and prostate cancer mortality in electric utility workers
Am. J. Epidemiol.
Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome
Cancer Res.
Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression
J. Cell Sci.
Arsenic as an endocrine disruptor: effects of arsenic on estrogen receptor-mediated gene expression in vivo and in cell culture
Toxicol. Sci.
Synthetic oestrogenic agents without phenanthrene nucleus
Nature
Retinoic acid receptors and cellular retinoid binding proteins I. A systematic study of their differential pattern of transcription during mouse organogenesis
Development
Predicting plasma concentrations of bisphenol A in children younger than 2 years of age after typical feeding schedules, using a physiologically based toxicokinetic model
Environ. Health Perspect.
Total serum testosterone and gonadotropins in workers exposed to dioxin
Am. J. Epidemiol.
Bilateral orchiectomy with or without flutamide for metastatic prostate cancer
N. Engl. J. Med.
Treating prostate cancer: a rationale for targeting local oestrogens
Nat. Rev.
Transgenerational and developmental exposure of Japanese medaka (Oryzias latipes) to ethinylestradiol results in endocrine and reproductive differences in the response to ethinylestradiol as adults
Toxicol. Sci.
Human prostate sphere-forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivo
Prostate
Intermediate basal cells of the prostate: in vitro and in vivo characterization
Prostate
Identification of a cell of origin for human prostate cancer
Science
Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics
PNAS
Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo
J. Exp. Med.
Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo
Cancer Res.
Serum dioxin, testosterone, and subsequent risk of benign prostatic hyperplasia: a prospective cohort study of Air Force veterans
Environ. Health Perspect.
Dioxin exposure and benign prostatic hyperplasia
J. Occup. Environ. Med.
Adipose tissue concentrations of persistent organic pollutants and the risk of prostate cancer
J. Occup. Environ. Med.
The fetal basis of adult disease: role of environmental exposures–introduction
Birth Defects Res., Part A: Clin. Mol. Teratol.
Endogenous hormones as a major factor in human cancer
Cancer Res.
The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring
Br. J. Cancer
Developmental exposure estradiol and bisphenol A (BPA) increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant (PDE4D4) in the rat prostate
Cancer Res.
Estrogen-initiated transformation of prostate epithelium derived from normal human prostate stem-progenitor cells
Endocrinology
Prostate epithelial stem cell culture
Cytotechnology
Cited by (105)
Development of cancer
2023, Personal Care Products and Human HealthEndocrine disruptors and endometriosis
2023, Reproductive ToxicologyEmerging organoid models to study the epididymis in male reproductive toxicology
2022, Reproductive ToxicologyCitation Excerpt :A principal characteristic of multipotent adult stem cells is their ability to differentiate into a cell type of the organ from which they originate. These organoid structures have been developed using adult stem cells from numerous tissues, including the epididymal basal cell organoids described previously [111,146–153]. In the rat, single cell dispersion of epididymal epithelium cultured under 3D conditions resulted in the development of spheres that resembled organoids [85,154].
Per- and polyfluoroalkyl substances target and alter human prostate stem-progenitor cells
2022, Biochemical Pharmacology